Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAlpha Growth Regulatory News (ALGW)

  • There is currently no data for ALGW

Proposed Placing

30 Apr 2019 07:20

RNS Number : 4749X
Alpha Growth PLC
30 April 2019
 

Alpha Growth plc

("Alpha", or the "Company")

 

Proposed Placing

 

Alpha Growth plc (LSE: ALGW), the financial services specialist in the growing Senior Life Settlement ("SLS") asset class, is pleased to announce the placing of new ordinary shares to raise gross proceeds of £450,000 (the "Placing"). 

 

Alpha Growth has today agreed to issue, conditional on publication of a prospectus, which is anticipated to happen in the coming days, and conditional on admission, 30,000,000 new ordinary shares of 0.1p each (the "Placing Shares") at a placing price of 1.5p per Placing Share, representing the last closing bid price of Alpha's shares. The Placing Shares will, subject to the publication of the prospectus and when issued, rank pari passu in all respects with the existing ordinary shares. An application will be made for the Placing Shares to be admitted to trading following the publication of a prospectus and admission is expected to take place shortly after, further updates will be announced.

 

The net proceeds of the Placing are expected to provide sufficient funding for existing operations for the next 12 months, strengthening the Company's cash position as it rolls out its product suite and unfolds its business plan to become a leading longevity asset manager in US life settlements.

 

The Company is also pleased to announce that Chief Operating Officer, Danny Swick, has subscribed for 750,000 of the placing shares on the same terms as above. Mr. Swick's previous holding was 750,000 shares (being 0.59% of the Company's issued share capital), and so this subscription takes his holding, immediately after admission of the placing shares, to a total of 1,500,000, being 0.96% of the enlarged issued share capital of the Company.

 

Following the publication of the prospectus and issue of the Placing Shares, the Company's issued share capital will consist of 156,635,000 ordinary shares, until then and as of 29 April the Company issued share capital is 126,635,000.

 

Gobind Sahney, Chairman of Alpha, commented:

"We are pleased to continue to receive good support from our corporate brokers as well as both new and existing shareholders in completing this funding. Having also today announced our fund launch, the Company is positioned to accelerate shareholder value with a variety of institutionally relevant products for investors in longevity assets as we embark on a more visible and tenacious investor marketing campaign."

 

The information communicated in this announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No. 596/2014.

For more information, please visit www.algwplc.com or contact the following:

 

Alpha Growth plc

+44 (0) 20 3959 8600

Gobind Sahney, Executive Chairman

info@algwplc.com

Novum Securities Limited (Corporate Broker)

+44 (0) 207 399 9400

Colin Rowbury

crowbury@novumsecurities.com

 

About Alpha Growth plc Specialist in Longevity Assets Alpha Growth plc is a financial advisory business providing specialist consultancy, advisory, and supplementary services to institutional and qualified investors globally in the multi-billion dollar market of longevity assets. Building on its well-established network, the Alpha Growth Group has a unique position in the longevity asset services and investment business, as a listed entity with global reach. The Group's strategy is to expand its advisory and business services via acquisitions and joint ventures in the UK and the US to attain commercial scale and provide wholistic solutions to alternative institutional investors who are in need of specialised skills and unique access to deploy their financial resource in longevity assets.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
IOECKCDDKBKBKQB
Date   Source Headline
2nd Apr 20257:00 amRNSHolding(s) in Company
2nd Apr 20257:00 amRNSDirector/PDMR Shareholding
27th Mar 20257:00 amRNS-RShareholder Update Call
25th Mar 20257:00 amRNSUnaudited Interim 2024 Annual Financial Report
19th Mar 20257:00 amRNSHolding(s) in Company
17th Mar 20253:42 pmRNSIntention to delist from London Stock Exchange
23rd Dec 20244:03 pmRNSNew Accounting Reference Date
12th Dec 202411:03 amRNSNon-Executive Director Appointment
27th Sep 20242:15 pmRNSHolding(s) in Company
17th Sep 20247:00 amRNSHalf-year Report
9th Sep 20247:00 amRNSAcquisition
25th Jun 20249:00 amRNSResult of AGM
6th Jun 20241:44 pmRNSHolding(s) in Company
17th May 20247:00 amRNSAcquisition Insurance Services Company
14th May 20243:39 pmRNSHolding(s) in Company
30th Apr 20241:00 pmRNSAnnual Financial Report
22nd Dec 20239:00 amRNSExpiration of Warrants
13th Dec 20237:00 amRNSAlpha International Life Receives KBRA Rating
14th Nov 20233:36 pmRNSJason Sutherland Receives Industry Recognition
9th Oct 20234:00 pmRNSHolding(s) in Company
9th Oct 20232:43 pmRNSHolding(s) in Company
29th Sep 202311:00 amRNSHalf-year Report
14th Aug 20236:29 pmRNSHolding(s) in Company
19th Jun 20237:00 amRNSResult of AGM
6th Jun 20237:00 amRNSNotice of AGM
15th May 20237:00 amRNSAcquisition of Minority Holding and Share Issuance
3rd May 20237:00 amRNSHolding(s) in Company
2nd May 20237:00 amRNS2022 Annual Report & Financial Statements
15th Mar 20237:00 amRNSWarrant Exercise and Total Voting Rights
6th Mar 20237:00 amRNS2022 Annual Recap and Fund Results
8th Feb 20234:40 pmRNSSecond Price Monitoring Extn
8th Feb 20234:35 pmRNSPrice Monitoring Extension
8th Feb 20231:10 pmRNSHolding(s) in Company
20th Jan 20232:05 pmRNSSecond Price Monitoring Extn
20th Jan 20232:00 pmRNSPrice Monitoring Extension
20th Jan 202311:05 amRNSSecond Price Monitoring Extn
20th Jan 202311:00 amRNSPrice Monitoring Extension
12th Dec 20227:00 amRNSFurther Regarding Havelet Acquisition
6th Dec 20227:00 amRNSCompletion of Share Purchase Acquisition
17th Nov 20227:00 amRNSFinancial Services Company Acquistion
27th Oct 20227:00 amRNSChange of Adviser
26th Oct 20224:41 pmRNSSecond Price Monitoring Extn
26th Oct 20224:36 pmRNSPrice Monitoring Extension
3rd Oct 20224:40 pmRNSSecond Price Monitoring Extn
3rd Oct 20224:35 pmRNSPrice Monitoring Extension
3rd Oct 20222:06 pmRNSSecond Price Monitoring Extn
3rd Oct 20222:00 pmRNSPrice Monitoring Extension
3rd Oct 202211:06 amRNSSecond Price Monitoring Extn
3rd Oct 202211:01 amRNSPrice Monitoring Extension
30th Sep 20227:00 amRNSHalf-year Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.